BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11965208)

  • 1. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute myocardial infarction: thrombolysis].
    Branzi A; Ortolani P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):711-5. PubMed ID: 12497809
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 8. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 9. ST-elevation myocardial infarction: New Zealand management guidelines.
    ;
    N Z Med J; 2005 Oct; 118(1223):U1679. PubMed ID: 16224503
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].
    Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
    An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolysis in acute myocardial infarction: current status.
    Kiernan TJ; Gersh BJ
    Med Clin North Am; 2007 Jul; 91(4):617-37; x. PubMed ID: 17640539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for pre-hospital administration of fibrinolytic therapy in New Zealand general practitioners.
    Pre-Hospital Fibrinolysis Guidelines Working Party
    N Z Med J; 2004 Jul; 117(1197):U958. PubMed ID: 15326511
    [No Abstract]   [Full Text] [Related]  

  • 14. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2003 Dec; 37(6):316-23. PubMed ID: 14668180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of failed thrombolysis after acute myocardial infarction: an overview of current treatment options.
    Mendoza CE; Bhatt MR; Virani S; Schob AH; Levine S; Ferreira AC; de Marchena E
    Int J Cardiol; 2007 Jan; 114(3):291-9. PubMed ID: 17079034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is intensive drug therapy appropriate for older patients?
    Gollub SB
    Lancet; 1999 Mar; 353(9157):940-1. PubMed ID: 10459896
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for acute myocardial infarction in the 1990s.
    Effron MB; Morales RE
    Md Med J; 1991 Jun; 40(6):485-91. PubMed ID: 1830634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.